文献速递传染病防控与疫情报告免疫规划

布鲁氏菌流产杆菌S19和RB51疫苗株在现场研究中有效性的系统综述

Systematic review on the effectiveness of Brucella abortus S19 and RB51 vaccine strains in field studies.
PubMed 文献 · Vaccine · 2024-12-21

该研究于2020年4月3日在六个数据库中检索1976至2016年发表的文献,最终纳入17篇论文、33项试验。多数试验采用横断面设计,S19株使用最多,20项试验显示疫苗接种对布鲁氏菌病控制有显著效果,但研究间异质性大,无法进行Meta分析。

要点

  • S19株用于75.76%(25/33)的试验,主要经皮下途径接种成年牛。
  • RB51株仅经皮下途径接种,用于年轻和成年动物。
  • 60.61%(20/33)的试验显示接种组感染发生率更低或接种后患病率降低。

核心结论

  • 综述结果提示S19和RB51疫苗株在犊牛和成年牛中均能有效降低布鲁氏菌病发病率及流产率,尤其是与其他控制政策联合应用时。

研究设计与样本

  • 系统综述于2020年4月3日在CABI、Cochrane、PubMed、Scielo、Scopus和Web of Science六个数据库中检索1976至2016年发表的论文。
  • 数据库检索共获得5846篇论文,另经专家建议补充6篇,最终纳入17篇论文,识别出33项试验。
  • 多数试验[63.63%(21/33)]采用患病率面板设计(横断面),其余为队列研究。

主要发现

  • S19株用于多数试验[75.76%(25/33)],主要经皮下途径[84.00%(21/25)]接种成年牛[76.00%(19/25)]。
  • RB51株仅经皮下途径接种,用于年轻和成年动物。
  • 病例定义最常使用补体结合试验[60.60%(20/33)]和利凡诺试验[30.30%(10/33)]。
  • 33项试验中20项(60.61%)显示疫苗接种对布鲁氏菌病控制有显著效果,接种组感染发生率更低(队列试验中)或接种后患病率降低(患病率面板中)。
  • 多数试验[57.57%(19/33)]同时采用其他控制措施(检测淘汰或隔离阳性动物),影响了对疫苗接种独立效果的评估。

局限性

  • 研究间存在极大异质性,无法对提取数据进行Meta分析。
  • 多数试验[57.57%(19/33)]同时采用其他控制措施,妨碍了更好理解疫苗接种在现场控制布鲁氏菌病中的独立效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Brucella abortus S19 and RB51 are the most used vaccines to control bovine brucellosis worldwide; therefore, this study aimed to perform a systematic review on the effectiveness of these two vaccine strains in field studies. The literature review was conducted on April 3rd 2020 on six databases (CABI, Cochrane, PubMed, Scielo, Scopus and Web of Science) and included papers published between 1976 and 2016. The search strategy recovered a total of 5846 papers on databases and 6 papers were included due to specialists' suggestions. After selection, 17 papers were included, in which 33 trials were identified. Most trials [63.63 % (21/33)] used prevalence panel design (cross-sectional), while the others were cohort studies. S19 strain was used in most of the trials [75.76 % (25/33)], mainly by subcutaneous route [84.00 % (21/25)] and in adult cattle [76.00 % (19/25)]. RB51 strain was administrated only by the subcutaneous route and in both young and adult animals. For case definition, complement fixation [60.60 % (20/33)] and rivanol [30.30 % (10/33)] were the most used tests. Twenty of the 33 trials (60.61 %) showed significant effect of vaccination on brucellosis control, with lower incidence of infection in the vaccinated groups (in cohort trials) or reduced prevalence after vaccination (in prevalence panels); however, the great heterogeneity observed among the studies precluded a meta-analysis from the data extracted. In addition, most trials [57.57 % (19/33)] adopted other control measures (test-and-slaughter or isolation of positive animals from the herd) in association with vaccination, which harmed the better understand of the isolated effect of vaccination for brucellosis control in field in these studies. In conclusion, the result from this review suggests that both S19 and RB51 vaccine strains are effective in reducing brucellosis incidence in both calves and adults, as well as abortion rates, mainly when associated to other control policies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Serpa Gonçalves M, de Oliveira MM, Andrade RS, et al. Systematic review on the effectiveness of Brucella abortus S19 and RB51 vaccine strains in field studies. Vaccine. 2024. PMID: 39709806. doi:10.1016/j.vaccine.2024.126649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。